Association between fibrinogen level and severity of postpartum haemorrhage: Secondary analysis of a prospective trial

British Journal of Anaesthesia

Volumn 108, Issue 6, 2012, Pages 984-989

  Cortet, M ^a,b,c,d   Deneux Tharaux, C ^e   Dupont, C ^f,g   Colin, C ^a   Rudigoz, R C ^f   Bouvier Colle, M H ^e   Huissoud, C ^b,f,h  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^e INSERM   (France)

^f CROIX ROUSSE HOSPITAL   (France)

^g UNIVERSITÉ DE LYON   (France)

^h STEM CELL AND BRAIN RESEARCH INSTITUTE   (France)

Author keywords

blood coagulation; fibrinogen; postpartum haemorrhage

Indexed keywords

FIBRINOGEN; HEMOGLOBIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; COMPARATIVE STUDY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EMERGENCY SURGERY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYSTERECTOMY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE ATONY; VAGINAL DELIVERY;

EID: 84861451009     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes096     Document Type: Article

References (25)

1. Selo-Ojeme DO. Primary postpartum haemorrhage. J Obstet Gynaecol 2002; 22: 463-9
2. Bouvier-Colle MH, Péquignot F, Jougla E. Maternal mortality in France: frequency, trends and causes. J Gynecol Obstet Biol Reprod (Paris) 2001; 30: 768-75
3. Mathai M, Gülmezoglu AM, Hill S. Saving women's lives: evidencebased recommendations for the prevention of postpartum haemorrhage. Bull World Health Organ 2007; 85: 322-3
4. Royal College of Obstetricians and Gynecologists. Prevention and management of postpartum haemorrhage. RCOG Green-top Guideline 2009; 52: 1-24
5. Goffinet F, Mercier F, Teyssier V, et al. Postpartum haemorrhage: recommendations for clinical practice by the CNGOF (December 2004). Gynecol Obstet Fertil 2005; 33: 268-74
6. Al-Zirqi I, Vangen S, Forsén L, Stray-Pedersen B. Effects of onset of labor and mode of delivery on severe postpartum hemorrhage. Am J Obstet Gynecol 2009; 201: 273.e1-e9
7. Bais JMJ, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (. or 1/4500 ml) and severe (. or 1/41000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004; 115: 166-72
8. Magann EF, Doherty DA, Briery CM, Niederhauser A, Chauhan SP, Morrison JC. Obstetric characteristics for a prolonged third stage of labor and risk for postpartum hemorrhage. Gynecol Obstet Invest 2008; 65: 201-5
9. Sosa CG, Althabe F, Belizán JM, Buekens P. Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol 2009; 113: 1313-9
10. Driessen M, Bouvier-Colle M-H, Dupont C, Khoshnood B, Rudigoz R-C, Deneux-Tharaux C. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity. Obstet Gynecol 2011; 117: 21-31
11. Huissoud C, Carrabin N, Benchaib M, et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thromb Haemost 2009; 101: 755-61
12. Sørensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834-43
13. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769-73
14. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73
15. Deneux-Tharaux C, Dupont C, Colin C, et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG 2010; 117: 1278-87
16. Mackie IJ, Kitchen S, Machin SJ, Lowe GDO. Guidelines on fibrinogen assays. Br J Haematol 2003; 121: 396-404
17. Chauleur C, Cochery-Nouvellon E, Mercier E, et al. Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. J Thromb Haemost 2008; 6: 2067-74
18. Simon L, Santi TM, Sacquin P, Hamza J. Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications. Br J Anaesth 1997; 78: 678-83
19. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5
20. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-21
21. Fries D, Innerhofer P, Reif C, et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 2006; 102: 347-51
22. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145: 24-33
23. Ducloy-Bouthors A-S, Blondé-Zoonekynd E, Jaillette E, et al. Transfusion and postpartum haemorrhage. Transfus Clin Biol 2010; 17: 273-8
24. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009; 102: 793-9
25. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogenlevel inpostpartumhaemorrhageby thrombelastometry. BJOG 2009; 116: 1097-102